{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:00:16Z","timestamp":1785387616272,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gouty arthritis(GA) is a common crystal-induced inflammatory arthropathy influenced by inflammatory, metabolic, renal, hematologic, demographic, and lifestyle-related factors. Because serum uric acid alone may not fully characterize GA in routine clinical settings, integrative models based on routinely available variables may improve disease classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study included 7,383 eligible adult participants from the electronic medical record database of the Affiliated Hospital of Jiangxi University of Chinese Medicine between September 1, 2020 and February 1, 2026. GA cases were retrospectively reconstructed according to the 2015 American College of Rheumatology\/European League Against Rheumatism classification framework, and non-gout comparators were drawn from a contemporaneous heterogeneous hospital population. Missing predictor values were handled using multiple imputation by chained equations after stratified training\/test splitting. Least absolute shrinkage and selection operator regression was used for feature selection. Four supervised learning algorithms were developed and internally evaluated using a 7:3 hold-out design, with cross-validation-based tuning within the training set. Model performance was assessed using discrimination, calibration, decision curve analysis, and confusion matrices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the four models, random forest showed the best overall performance. In the training set, it achieved an area under the receiver operating characteristic curve of 0.8995, accuracy of 0.7062, sensitivity of 0.9623, positive predictive value of 0.6094, and negative predictive value of 0.9419. In the test set, it remained the best-performing model, with an area under the receiver operating characteristic curve of 0.8686, accuracy of 0.6980, sensitivity of 0.9442, positive predictive value of 0.6048, and negative predictive value of 0.9163. Support vector machine ranked second, whereas k-nearest neighbors and logistic regression showed weaker discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A machine-learning model based on routinely available hospital variables, particularly random forest, showed favorable internal discrimination for GA classification and outperformed conventional logistic regression. These findings support its use as a preliminary screening-oriented classification aid rather than a stand-alone diagnostic tool. External validation remains necessary before broader clinical deployment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1869807","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:01Z","timestamp":1785385321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and internal validation of machine learning models for gouty arthritis classification using routine clinical variables: a retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Weiwei","family":"Ma","sequence":"first","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Sun","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Liang","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanan","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]},{"name":"Hospital Affiliated to Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s40265-023-01944-y","article-title":"Emerging urate-lowering drugs and pharmacologic treatment strategies for Gout: a narrative review","volume":"83","author":"Terkeltaub","year":"2023","journal-title":"Drugs."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e013191","DOI":"10.1136\/bmjopen-2016-013191","article-title":"Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies","volume":"6","author":"Jamnik","year":"2016","journal-title":"BMJ Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1186\/s12889-025-23319-6","article-title":"Associations of circadian syndrome with gout and hyperuricemia: a cross-sectional analysis of NHANES 2007-2018","volume":"25","author":"Ren","year":"2025","journal-title":"BMC Public Health."},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"738466","DOI":"10.3389\/fpsyt.2021.738466","article-title":"Use of machine learning and artificial intelligence methods in geriatric mental health research involving electronic health record or administrative claims data: a systematic review","volume":"12","author":"Chowdhury","year":"2021","journal-title":"Front Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 Gout classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.7326\/ANNALS-24-01516","article-title":"Addressing missingness in predictive models that use electronic health record data","volume":"178","author":"Lin","year":"2025","journal-title":"Ann Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e096275","DOI":"10.1136\/bmjopen-2024-096275","article-title":"Development, validation and clinical utility of prognostic models for patients with traumatic brain injury in an indian setting using machine learning and traditional approaches: a study protocol","volume":"15","author":"Kamal","year":"2025","journal-title":"BMJ Open."},{"key":"B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ALN.0000000000003871","article-title":"Statistical development and validation of clinical prediction models","volume":"135","author":"Staffa","year":"2021","journal-title":"Anesthesiology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/aogs.14757","article-title":"Investigation of statistical methods used in prognostic prediction models for obstetric care: a 10 year-span cross-sectional study","volume":"103","author":"Tan","year":"2024","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e074820","DOI":"10.1136\/bmj-2023-074820","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41065-019-0103-y","article-title":"ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population","volume":"156","author":"Zhang","year":"2019","journal-title":"Hereditas"},{"key":"B15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41584-024-01092-x","article-title":"The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout","volume":"20","author":"Yokose","year":"2024","journal-title":"Nat Rev Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/ANNALS-24-03951","article-title":"Gout","volume":"178","author":"FitzGerald","year":"2025","journal-title":"Ann Internal Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/08820139.2023.2168554","article-title":"Genetic and epigenetic regulation of the innate immune response to gout","volume":"52","author":"de Lima","year":"2023","journal-title":"Immunol Investig."},{"key":"B18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41584-024-01137-1","article-title":"The pathogenesis of gout: Molecular insights from genetic, epigenomic and transcriptomic studies","volume":"20","author":"Leask","year":"2024","journal-title":"Nature Rev Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2430700","DOI":"10.1001\/jamanetworkopen.2024.30700","article-title":"Consumption of total and specific alcoholic beverages and long-term risk of gout among men and women","volume":"7","author":"Lyu","year":"2024","journal-title":"JAMA Network Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1588980","DOI":"10.3389\/fnut.2025.1588980","article-title":"Impact of alcohol consumption on hyperuricemia and gout: a systematic review and meta-analysis","volume":"12","author":"Ma","year":"2025","journal-title":"Front Nutrit."},{"key":"B22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12902-024-01747-6","article-title":"The association between triglyceride glucose index and gout: a cross-sectional analysis based on NHANES 2007\u20132018","volume":"24","author":"Dai","year":"2024","journal-title":"BMC Endocr Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e14129","DOI":"10.1111\/eci.14129","article-title":"Assessing the causal association between human blood metabolites and the risk of gout","volume":"54","author":"Xie","year":"2024","journal-title":"Eur J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/biomedicines12020300","article-title":"Plasma and urinary metabolomic analysis of gout and asymptomatic hyperuricemia and profiling of potential biomarkers: a pilot study","volume":"12","author":"Ohashi","year":"2024","journal-title":"Biomedicines."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/rheumatology\/keae273","article-title":"A machine learning-based prediction model for gout in hyperuricemics: a nationwide cohort study","volume":"63","author":"Brikman","year":"2024","journal-title":"Rheumatology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1208\/s12248-021-00644-3","article-title":"Machine learning and artificial intelligence in pharmaceutical research and development: a review","volume":"24","author":"Kolluri","year":"2022","journal-title":"AAPS J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): From development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1097\/PR9.0000000000001382","article-title":"Predicting high health care use in patients with spinal disorder in secondary care: model development and validation","volume":"11","author":"Kj\u00f8n\u00f8","year":"2026","journal-title":"Pain Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41746-024-01340-0","article-title":"Learning from the EHR to implement AI in healthcare","volume":"7","author":"Rose","year":"2024","journal-title":"NPJ Digit Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e074821","DOI":"10.1136\/bmj-2023-074821","article-title":"Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1530799","DOI":"10.3389\/fpubh.2025.1530799","article-title":"Revolutionizing e-health: the transformative role of AI-powered hybrid chatbots in healthcare solutions","volume":"13","author":"Wah","year":"2025","journal-title":"Front Public Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e79307","DOI":"10.2196\/79307","article-title":"Methods for addressing missingness in electronic health record data for clinical prediction models: comparative evaluation","volume":"13","author":"Digitale","year":"2025","journal-title":"JMIR Med Inform."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1869807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:02Z","timestamp":1785385322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1869807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":33,"alternative-id":["10.3389\/fmed.2026.1869807"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1869807","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1869807"}}